The journal’s new status and its inclusion in the Scientific Electronic Library of the Russian Federation database for indexing in the Russian Science Citation Index (RSCI, as of December 30, 2020) imposes special requirements for the quality of published materials. The introduction of new requirements for manuscript formatting is primarily driven by the desire to follow global trends in the development of evidence-based medicine and meet international quality standards for scientific publications.
The editorial board of the Eurasian Scientific Medical Journal “Sino” hopes that strict adherence to these requirements by authors of manuscripts will help significantly improve the quality of the journal and its citation rate by domestic and international researchers.
The review of manuscripts by the editorial board of the Eurasian Scientific Medical Journal “Sino”
is carried out in 2 stages (review levels):
Stage I – express assessment of the manuscript for compliance with the requirements for materials submitted for publication in the Eurasian Scientific Medical Journal “Sino”. Express evaluation of the manuscript is carried out by the editor-in-chief of the journal (open peer review – the author and reviewer know each other). In case of non-compliance of the submitted manuscript with the requirements for materials sent for publication in the journal, the editor-in-chief notifies the author(s) of the results of the express evaluation of the manuscript and rejects the manuscript from further review.
Stage II – the review itself. If the submitted manuscript meets the requirements for materials sent for publication in the journal, the editor-in-chief sends it for review to external reviewers – scientists and specialists in this field (Doctor, Candidate of Sciences), who have published on the topic of the article under review over the past 3 years (two-way “blind” review (single-blind – the reviewer does not know the author of the article, and the author does not know the reviewer). Specialists working in the same research institute are not involved in the review the institution where the work was performed.
The reviewer evaluates the manuscript according to the manuscript review form (in the approved format). The requirements of the manuscript review form are based on the “Uniform Requirements for Manuscripts Submitted to Biomedical Journals” developed by the International Committee of Medical Journal Editors (ICMJE), which includes editors of such internationally recognized journals as the Journal of the American Medical Association (JAMA), The Lancet, the New England Journal of Medicine (NEJM), the Journal of the Norwegian Medical Association (Tidsskrift for Den Norske Legeforening), the Croatian Medical Journal (CMJ), and others.
If The reviewer recommends the article for publication after revision, taking into account the comments, or does not recommend the article for publication – the review must indicate the reasons for such a decision.
If there is a negative review of the manuscript, the article is rejected without consideration by other members of the editorial board. In case of disagreement with the reviewer’s opinion, the author has the right to submit a reasoned objection to the Editors. The manuscript, with the consent of the editorial board, may be sent for a second (additional) review.
The reviewer is responsible for the work under review.
The editor-in-chief keeps track of the movement of manuscripts received by the editors, and also informs the authors of the decision taken on a specific article.
The maximum review period between the dates of receipt of the manuscript by the editors and the editorial board’s decision is 1 month.
The editor-in-chief presents the portfolio of the next issue of the Eurasian Scientific Medical Journal to the editor-in-chief “Sino” for approval.
Original reviews are subject to storage at the journal’s editorial office for 5 years from the date of publication.